1. Home
  2. ICUCW vs JAKK Comparison

ICUCW vs JAKK Comparison

Compare ICUCW & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • JAKK
  • Stock Information
  • Founded
  • ICUCW N/A
  • JAKK 1995
  • Country
  • ICUCW United States
  • JAKK United States
  • Employees
  • ICUCW 12
  • JAKK N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • JAKK Recreational Games/Products/Toys
  • Sector
  • ICUCW Health Care
  • JAKK Consumer Discretionary
  • Exchange
  • ICUCW Nasdaq
  • JAKK Nasdaq
  • Market Cap
  • ICUCW N/A
  • JAKK N/A
  • IPO Year
  • ICUCW 2021
  • JAKK 1996
  • Fundamental
  • Price
  • ICUCW $0.03
  • JAKK $26.65
  • Analyst Decision
  • ICUCW
  • JAKK Strong Buy
  • Analyst Count
  • ICUCW 0
  • JAKK 4
  • Target Price
  • ICUCW N/A
  • JAKK $41.25
  • AVG Volume (30 Days)
  • ICUCW N/A
  • JAKK 78.3K
  • Earning Date
  • ICUCW N/A
  • JAKK 10-30-2024
  • Dividend Yield
  • ICUCW N/A
  • JAKK N/A
  • EPS Growth
  • ICUCW N/A
  • JAKK N/A
  • EPS
  • ICUCW N/A
  • JAKK 2.99
  • Revenue
  • ICUCW N/A
  • JAKK $687,697,000.00
  • Revenue This Year
  • ICUCW N/A
  • JAKK N/A
  • Revenue Next Year
  • ICUCW N/A
  • JAKK $3.56
  • P/E Ratio
  • ICUCW N/A
  • JAKK $8.90
  • Revenue Growth
  • ICUCW N/A
  • JAKK N/A
  • 52 Week Low
  • ICUCW N/A
  • JAKK $17.06
  • 52 Week High
  • ICUCW N/A
  • JAKK $36.84
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • JAKK 43.05
  • Support Level
  • ICUCW N/A
  • JAKK $26.10
  • Resistance Level
  • ICUCW N/A
  • JAKK $28.47
  • Average True Range (ATR)
  • ICUCW 0.00
  • JAKK 0.81
  • MACD
  • ICUCW 0.00
  • JAKK -0.23
  • Stochastic Oscillator
  • ICUCW 0.00
  • JAKK 22.57

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: